Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex acquired eCredit, a service for car loans

6/4/24 YDEX

Severstal presented its development strategy until 2028

6/4/24 CHMF

Revenue of Mosgorlombard for January-May increased by 4.7 times

6/4/24 MGKL

IVA Technologies IPO will take place at the top of the range

6/4/24 IVAT

Shareholders of Agregat approved dividends for 2023

6/4/24 AGRT

Shareholders of Europlan approved dividends for 2023

6/4/24 LEAS

Find the Job has opened a round of investment raising

6/3/24 OTCI

RusHydro to commission 2.4 GW of power capacity by 2028

6/3/24 HYDR

TMK cancels SPO due to unfavorable market conditions

6/3/24 TRMK

Board of Directors of Abrau-Durso recommended that dividends be paid for 2023

6/3/24 ABRD